cisatracurium-aft
aft pharmaceuticals ltd - cisatracurium besilate 0.669%{relative} equivalent to cisatracurium 0.5% w/v - solution for injection - 5 mg/ml - active: cisatracurium besilate 0.669%{relative} equivalent to cisatracurium 0.5% w/v excipient: benzenesulfonic acid water for injection - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.
cisatracurium pfizer cisatracurium (as besilate) 10 mg/5 ml solution for injection ampoule
pfizer australia pty ltd - cisatracurium besilate -
cisatracurium pfizer cisatracurium (as besilate) 5 mg/2.5 ml solution for injection ampoule
pfizer australia pty ltd - cisatracurium besilate -
cisatracurium 2 mg/ml solution for injection/infusion
as kalceks - cisatracurium besilate; cisatracurium - solution for injection/infusion - 2 milligram(s)/millilitre - cisatracurium
atracurium kalceks 10 mg/ml solution for injection/infusion - 2.5ml
as kalceks krustpils iela 71e, riga, lv-1057,, latvia - atracurium besilate - solution for injection/infusion - atracurium besilate 10 mg/ml - muscle relaxants
atracurium kalceks 10 mg/ml solution for injection/infusion - 5ml
as kalceks krustpils iela 71e, riga, lv-1057,, latvia - atracurium besilate - solution for infusion or injection - atracurium besilate 10 mg/ml - muscle relaxants
cisatracurium besylate injection solution
accord healthcare inc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
atracurium 10 mg/ml solution for injection/infusion
hikma farmacêutica (portugal) s.a. - atracurium besilate - solution for injection/infusion - 10 milligram(s)/millilitre - other quaternary ammonium compounds; atracurium
cisatracurium 2 mg/ml solution for injection/infusion
noridem enterprises limited - cisatracurium - solution for injection/infusion - 2 milligram(s)/millilitre - other quaternary ammonium compounds; cisatracurium
cisatracurium accord cisatracurium (as besilate) 150 mg / 30 ml solution for injection vial
accord healthcare pty ltd - cisatracurium besilate, quantity: 201 mg (equivalent: cisatracurium, qty 150 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit